News & Events

HTG Molecular Diagnostics Expands Its IVD Agreement With Illumina to Increase the Number of Test Kits

HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents and services for molecular profiling applications, announced that it has amended and restated its IVD Test Development and Component Supply Agreement with Illumina to, among other things, extend the agreement term and increase the number of in-vitro diagnostic (IVD) test kits that may be developed for use with Illumina sequencing technology.

full press release

Posted on:

Return To List

Page last updated December 20, 2017